Axcend Launches Full-Stack Chromatography System, Expanding Focus LC Line

Axcend Launches Full-Stack Chromatography System, Expanding Focus LC Line

Axcend Unveils Full-Stack Chromatography System, Revolutionizing Liquid Chromatography Axcend®, the leader in compact capillary liquid chromatography, has announced the launch of its groundbreaking small-footprint, full-stack chromatography system, which allows scientists to perform High-Performance Liquid Chromatography (HPLC) anywhere. Built on the…

Read MoreAxcend Launches Full-Stack Chromatography System, Expanding Focus LC Line
Seequent Evo Introducing Revolutionizing Geoscience Collaboration and Data Management

Seequent Evo Introducing : Revolutionizing Geoscience Collaboration and Data Management

Seequent Launches Evo: Revolutionizing Geoscience Data Collaboration and Management Seequent, the Bentley Subsurface Company, has unveiled Seequent Evo, a cloud-based platform designed to centralize geoscience data and enhance collaboration across industries reliant on this data, particularly mining. With the ability…

Read MoreSeequent Evo Introducing : Revolutionizing Geoscience Collaboration and Data Management
Protagonist and Takeda Announce Positive Phase 3 VERIFY Results

Protagonist and Takeda Announce Positive Phase 3 VERIFY Results for Rusfertide in Polycythemia Vera

Protagonist and Takeda Announce Positive Topline Results from Phase 3 VERIFY Study of Rusfertide in Polycythemia Vera Introduction to the VERIFY StudyProtagonist Therapeutics, Inc. and Takeda have announced the successful topline results of the Phase 3 VERIFY study, which evaluated…

Read MoreProtagonist and Takeda Announce Positive Phase 3 VERIFY Results for Rusfertide in Polycythemia Vera
ICR and Royal Marsden Study Highlights ctDNA Testing for Early-Stage Breast Cancer Recurrence

ICR and Royal Marsden Study Highlights ctDNA Testing for Early-Stage Breast Cancer Recurrence

Personalis and Royal Marsden Study Advances Early-Stage Breast Cancer Detection with NeXT Personal® ctDNA Test ICR and Royal Marsden Study Highlights ctDNA Testing Introduction: Advancements in Breast Cancer DetectionPersonalis, Inc. has partnered with renowned researchers from The Institute of Cancer…

Read MoreICR and Royal Marsden Study Highlights ctDNA Testing for Early-Stage Breast Cancer Recurrence
Celltrion's Avtozma® (CT-P47) Biosimilar Receives European Commission Approval

Celltrion’s Avtozma® (CT-P47) Biosimilar Receives European Commission Approval

Celltrion’s Avtozma® (CT-P47) Biosimilar Receives European Commission Approval Celltrion has announced that the European Commission (EC) has granted marketing authorization for Avtozma® (CT-P47), a biosimilar to RoActemra® (tocilizumab). Avtozma® is approved for all indications of its reference product, RoActemra®, including…

Read MoreCelltrion’s Avtozma® (CT-P47) Biosimilar Receives European Commission Approval